Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether Vitamin D improves eradication of drug-resistant Helicobacter pylori. The sponsor is the Chinese University of Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: H. Pylori Infection | Phase 3 | Status: UNKNOWN